Undesired Effect of Vancomycin Prolonged Treatment: Enhanced Biofilm Production of the Nosocomial Pathogen Candida auris
暂无分享,去创建一个
[1] Rita P. Ribeiro,et al. Essential Oils as a Good Weapon against Drug-Resistant Candida auris , 2022, Antibiotics.
[2] M. Guida,et al. Activity of Free and Liposome-Encapsulated Essential Oil from Lavandula angustifolia against Persister-Derived Biofilm of Candida auris , 2021, Antibiotics.
[3] D. Castelo-Branco,et al. Trichosporon asahii and Trichosporon inkin Biofilms Produce Antifungal-Tolerant Persister Cells , 2021, Frontiers in Cellular and Infection Microbiology.
[4] M. Billamboz,et al. Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris , 2021, Microorganisms.
[5] Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer , 2021, Advances in Medical Technologies and Clinical Practice.
[6] J. Osatnik,et al. [Epidemiological analysis of catheter-related bloodstream infections in medical-surgical intensive care units]. , 2021, Medicina.
[7] A. Tsakris,et al. Central venous catheter-related bloodstream infection and colonization: the impact of insertion site and distribution of multidrug-resistant pathogens , 2020, Antimicrobial Resistance & Infection Control.
[8] A. Macêdo,et al. Alternative method in Galleria mellonella larvae to study biofilm infection and treatment. , 2019, Microbial pathogenesis.
[9] F. Groppo,et al. Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm , 2019, Front. Pharmacol..
[10] A. Fife,et al. Candida auris outbreak: Mortality, interventions and cost of sustaining control. , 2019, The Journal of infection.
[11] G. Garcia-Effron,et al. Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris. , 2019, The Journal of antimicrobial chemotherapy.
[12] R. Cordeiro,et al. Cefepime and Amoxicillin Increase Metabolism and Enhance Caspofungin Tolerance of Candida albicans Biofilms , 2019, Front. Microbiol..
[13] Maneesha K. Suresh,et al. An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms. , 2019, International journal of medical microbiology : IJMM.
[14] O. Cornely,et al. Essentials in Candida bloodstream infection , 2018, Infection.
[15] E. Abdala,et al. Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria , 2018, Antimicrobial Agents and Chemotherapy.
[16] B. Kullberg,et al. Invasive Candidiasis. , 2019, The New England journal of medicine.
[17] M. Pujol,et al. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia , 2017, Expert opinion on pharmacotherapy.
[18] Zhìhóng Hú,et al. Recent Advances in Ergosterol Biosynthesis and Regulation Mechanisms in Saccharomyces cerevisiae , 2017, Indian Journal of Microbiology.
[19] A. Borman,et al. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris , 2017, Emerging infectious diseases.
[20] J. Meis,et al. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. , 2016, The Journal of infection.
[21] A. Chowdhary,et al. Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation , 2016, New microbes and new infections.
[22] M. Shams-Ghahfarokhi,et al. Cold atmospheric plasma inhibits the growth of Candida albicans by affecting ergosterol biosynthesis and suppresses the fungal virulence factors in vitro. , 2016, Photodiagnosis and photodynamic therapy.
[23] U. Tatu,et al. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris , 2015, BMC Genomics.
[24] Ning Mao,et al. Efficacy of Combined Vancomycin and Fosfomycin against Methicillin-Resistant Staphylococcus aureus in Biofilms In Vivo , 2014, PloS one.
[25] V. Fowler,et al. Clinical management of Staphylococcus aureus bacteremia: a review. , 2014, JAMA.
[26] M. Cooper,et al. Glycopeptide antibiotics: Back to the future , 2014, The Journal of Antibiotics.
[27] N. Govender,et al. Candida auris–Associated Candidemia, South Africa , 2014, Emerging infectious diseases.
[28] Parth Malik,et al. Relationship of Azole Resistance with the Structural Alteration of the Target Sites: Novel Synthetic Compounds for Better Antifungal Activities , 2014 .
[29] M. Treiber,et al. Rifampicin induced virulence determinants increase Candida albicans biofilm formation , 2013 .
[30] George Y. Liu,et al. Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. , 2012, The Journal of antimicrobial chemotherapy.
[31] Jong-Hee Shin,et al. First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris , 2011, Journal of Clinical Microbiology.
[32] M. Treiber,et al. Rifampicin induces MDR1 expression in Candida albicans. , 2008, The Journal of antimicrobial chemotherapy.
[33] M. Ghannoum,et al. Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.
[34] G. Horgan,et al. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .
[35] M. Ghannoum,et al. Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces , 2002, Infection and Immunity.
[36] S. Stepanović,et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. , 2000, Journal of microbiological methods.
[37] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .